Search results
Search results from www.aesgp.eu
| Ingredient | ATC Level 1 | ATC Level 2 | Year Of Switch | Country | Status | Additional Information |
|---|---|---|---|---|---|---|
| Nitro-glycerine | C Cardiovascular system. Cardiovascular system | C01. Cardiac therapy | — | Argentina | Rx | — |
| Nitro-glycerine | C Cardiovascular system. Cardiovascular system | C01. Cardiac therapy | — | Australia | OTC | Known in Australia as Glyceryl trinitrate. S3 (pharmacist only) in preparations for oral use and in preparations for rectal use. All other preparations are S4 (prescription). Advertising to the general public is not permitted. |
| Nitro-glycerine | C Cardiovascular system. Cardiovascular system | C01. Cardiac therapy | — | Austria | Rx | — |
| Nitro-glycerine | C Cardiovascular system. Cardiovascular system | C01. Cardiac therapy | — | Belgium | Rx | — |
| Nitro-glycerine | C Cardiovascular system. Cardiovascular system | C01. Cardiac therapy | — | Bulgaria | Rx | — |
| Nitro-glycerine | C Cardiovascular system. Cardiovascular system | C01. Cardiac therapy | — | Canada | OTC | Ethical OTC status (medicine which does not require a prescription but is generally prescribed by a medical practitioner). |
| Nitro-glycerine | C Cardiovascular system. Cardiovascular system | C01. Cardiac therapy | — | Chile | Rx | — |
| Nitro-glycerine | C Cardiovascular system. Cardiovascular system | C01. Cardiac therapy | — | China | Rx | — |
| Nitro-glycerine | C Cardiovascular system. Cardiovascular system | C01. Cardiac therapy | — | Colombia | Rx | — |
| Nitro-glycerine | C Cardiovascular system. Cardiovascular system | C01. Cardiac therapy | — | Croatia | Rx | — |
| Nitro-glycerine | C Cardiovascular system. Cardiovascular system | C01. Cardiac therapy | — | Czech Republic | N.R. | Not registered or not marketed. |
| Nitro-glycerine | C Cardiovascular system. Cardiovascular system | C01. Cardiac therapy | — | Denmark | OTC | — |
| Nitro-glycerine | C Cardiovascular system. Cardiovascular system | C01. Cardiac therapy | — | Estonia | N.R. | Not registered or not marketed. |
| Nitro-glycerine | C Cardiovascular system. Cardiovascular system | C01. Cardiac therapy | — | Finland | Rx | — |
| Nitro-glycerine | C Cardiovascular system. Cardiovascular system | C01. Cardiac therapy | 1957 | France | OTC | All forms are OTC. 0.002% per intake, 0.0004g per unit and maximum 0.004g per pack. No product currently marketed. |
| Nitro-glycerine | C Cardiovascular system. Cardiovascular system | C01. Cardiac therapy | — | Germany | Rx | — |
| Nitro-glycerine | C Cardiovascular system. Cardiovascular system | C01. Cardiac therapy | — | Greece | Rx | — |
| Nitro-glycerine | C Cardiovascular system. Cardiovascular system | C01. Cardiac therapy | — | Hungary | N.R. | Not registered or not marketed. |
| Nitro-glycerine | C Cardiovascular system. Cardiovascular system | C01. Cardiac therapy | — | Ireland | Rx | — |
| Nitro-glycerine | C Cardiovascular system. Cardiovascular system | C01. Cardiac therapy | — | Italy | Rx | — |
| Nitro-glycerine | C Cardiovascular system. Cardiovascular system | C01. Cardiac therapy | — | Japan | Rx | — |
| Nitro-glycerine | C Cardiovascular system. Cardiovascular system | C01. Cardiac therapy | — | Lithuania | Rx | — |
| Nitro-glycerine | C Cardiovascular system. Cardiovascular system | C01. Cardiac therapy | — | Mexico | Rx | — |
| Nitro-glycerine | C Cardiovascular system. Cardiovascular system | C01. Cardiac therapy | — | New Zealand | OTC | Pharmacist only medicine for oral, sublingual or rectal use. |
| Nitro-glycerine | C Cardiovascular system. Cardiovascular system | C01. Cardiac therapy | — | Norway | Rx | — |
| Nitro-glycerine | C Cardiovascular system. Cardiovascular system | C01. Cardiac therapy | — | Philippines | Rx | — |
| Nitro-glycerine | C Cardiovascular system. Cardiovascular system | C01. Cardiac therapy | — | Poland | Rx | — |
| Nitro-glycerine | C Cardiovascular system. Cardiovascular system | C01. Cardiac therapy | — | Portugal | Rx | — |
| Nitro-glycerine | C Cardiovascular system. Cardiovascular system | C01. Cardiac therapy | — | Romania | Rx | ~Transdermal therapeutic patch ~Box containing 10 sachets/ two Nitroderm TTS 10 transdermal patches per day. ~Sublingual tablet ~Box with 2 PVC-PVDC/Al blisters of 10 sublingual tablets./1-2 tablets ~Sublingual spray, solution ~Box with an aluminum bottle, containing 180 doses,/1 dose (puff= 400 µg)/Prophylactically, the recommended dose is 0.4-0.8 mg, which corresponds to 1-2 doses (puffs). ~Prolonged-release tablets ~ Box with a glass vial containing 60 prolonged-release tablets/5.2 – 7.8 mg glyceryl trinitrate (2 - 3 Nitromint 2.6 mg tablets) twice a day. ~Infusion solution ~Box with 10 brown glass ampoules, containing 25 ml of infusion solution/dose of 0.5-1.0 mg glyceryl trinitrate per hour and adjust the dose according to individual needs. The maximum dose is normally 8 mg glyceryl trinitrate per hour, rarely reaching 10 mg per hour. |
| Nitro-glycerine | C Cardiovascular system. Cardiovascular system | C01. Cardiac therapy | — | Russia | — | No information. |
| Nitro-glycerine | C Cardiovascular system. Cardiovascular system | C01. Cardiac therapy | 2000 | Singapore | OTC | Glyceryl trinitrate transdermal preparations. |
| Nitro-glycerine | C Cardiovascular system. Cardiovascular system | C01. Cardiac therapy | — | Slovak Republic | Rx | — |
| Nitro-glycerine | C Cardiovascular system. Cardiovascular system | C01. Cardiac therapy | — | Slovenia | Rx | — |
| Nitro-glycerine | C Cardiovascular system. Cardiovascular system | C01. Cardiac therapy | — | South Korea | Rx | — |
| Nitro-glycerine | C Cardiovascular system. Cardiovascular system | C01. Cardiac therapy | — | Spain | Rx | — |
| Nitro-glycerine | C Cardiovascular system. Cardiovascular system | C01. Cardiac therapy | — | Sweden | N.R. | Not registered or not marketed. |
| Nitro-glycerine | C Cardiovascular system. Cardiovascular system | C01. Cardiac therapy | — | Switzerland | Rx | — |
| Nitro-glycerine | C Cardiovascular system. Cardiovascular system | C01. Cardiac therapy | — | The Netherlands | Rx | — |
| Nitro-glycerine | C Cardiovascular system. Cardiovascular system | C01. Cardiac therapy | — | UK | OTC | Pharmacy only status. |
| Nitro-glycerine | C Cardiovascular system. Cardiovascular system | C01. Cardiac therapy | — | USA | Rx | — |
| Nitro-glycerine | C Cardiovascular system. Cardiovascular system | C01. Cardiac therapy | — | Venezuela | Rx | — |
- 41 ingredients